EX-23.1 7 a2239789zex-23_1.htm EX-23.1

Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


The Board of Directors

Entasis Therapeutics Holdings Inc.:


We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.






Cambridge, Massachusetts


October 1, 2019